<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37836771</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1420-3049</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>19</Issue><PubDate><Year>2023</Year><Month>Oct</Month><Day>04</Day></PubDate></JournalIssue><Title>Molecules (Basel, Switzerland)</Title><ISOAbbreviation>Molecules</ISOAbbreviation></Journal><ArticleTitle>Synthesis and Characterization of Edaravone Analogues as Remyelinating Agents and Putative Mechanistic Probes.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">6928</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/molecules28196928</ELocationID><Abstract><AbstractText>Edaravone (EDA), an antioxidant drug approved for the treatment of ischemic stroke and amyotrophic lateral sclerosis, was recently proposed as a remyelinating candidate for the treatment of multiple sclerosis. Here, we synthesized twelve EDA analogues <b>2b</b>-<b>4c</b> showing three substitution patterns <b>A</b>-<b>C</b>, searching for improved remyelinating agents and putative molecular targets responsible for their regenerative activity. We profiled them in three primary assays to determine their stimulation of oligodendrocyte progenitor cell metabolism (tetrazolium MTT assay), their antioxidant potential (2,2-diphenyl-1-picrylhydrazyl-DPPH assay) and to predict their bioavailability (virtual ADME profile). Active 4'-carboxylate <b>2b</b>, 4'-ester 2c and N<sup>1</sup>-carbamate-4'-ester <b>4a</b> were further characterized, justifying their in vitro effects and selecting <b>4a</b> as a putative EDA 1 prodrug suitable for in vivo testing.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Colombo</LastName><ForeName>Eleonora</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-9062-4850</Identifier><AffiliationInfo><Affiliation>Chemistry Department, University of Milan, Via Golgi 19, 20133 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olla</LastName><ForeName>Stefania</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-8735-671X</Identifier><AffiliationInfo><Affiliation>Biomedical and Genetic Research Institute (IRGB, National Research Council (CNR)), University Campus, Monserrato, 09042 Monserrato, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Minnelli</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-8034-8557</Identifier><AffiliationInfo><Affiliation>Department of Life and Environmental Sciences, Marche Polytechnic University, Via Brecce Bianche, 60131 Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Formato</LastName><ForeName>Alessia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, National Institute of Health (ISS), Viale Regina Elena 299, 00161 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Veroni</LastName><ForeName>Caterina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, National Institute of Health (ISS), Viale Regina Elena 299, 00161 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corbisiero</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-7360-6570</Identifier><AffiliationInfo><Affiliation>Department of Neuroscience, National Institute of Health (ISS), Viale Regina Elena 299, 00161 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pericolo</LastName><ForeName>Mattia</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Chemistry Department, University of Milan, Via Golgi 19, 20133 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siguri</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Biomedical and Genetic Research Institute (IRGB, National Research Council (CNR)), University Campus, Monserrato, 09042 Monserrato, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mobbili</LastName><ForeName>Giovanna</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-0243-5844</Identifier><AffiliationInfo><Affiliation>Department of Life and Environmental Sciences, Marche Polytechnic University, Via Brecce Bianche, 60131 Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agresti</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-9225-7190</Identifier><AffiliationInfo><Affiliation>Department of Neuroscience, National Institute of Health (ISS), Viale Regina Elena 299, 00161 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seneci</LastName><ForeName>Pierfausto</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-9709-7344</Identifier><AffiliationInfo><Affiliation>Chemistry Department, University of Milan, Via Golgi 19, 20133 Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2017/R/2</GrantID><Agency>Fondazione Italiana Sclerosi Multipla</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Molecules</MedlineTA><NlmUniqueID>100964009</NlmUniqueID><ISSNLinking>1420-3049</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>S798V6YJRP</RegistryNumber><NameOfSubstance UI="D000077553">Edaravone</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000975">Antioxidants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004952">Esters</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077553" MajorTopicYN="N">Edaravone</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000975" MajorTopicYN="Y">Antioxidants</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004952" MajorTopicYN="N">Esters</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">absorption-distribution-metabolism-excretion (ADME)</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">antioxidant activity</Keyword><Keyword MajorTopicYN="N">chemical probes</Keyword><Keyword MajorTopicYN="N">edaravone</Keyword><Keyword MajorTopicYN="N">mechanism of action</Keyword><Keyword MajorTopicYN="N">medicinal chemistry</Keyword><Keyword MajorTopicYN="N">prodrugs</Keyword><Keyword MajorTopicYN="N">remyelination</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>9</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>23</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>14</Day><Hour>10</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>14</Day><Hour>1</Hour><Minute>19</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37836771</ArticleId><ArticleId IdType="pmc">PMC10574562</ArticleId><ArticleId IdType="doi">10.3390/molecules28196928</ArticleId><ArticleId IdType="pii">molecules28196928</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>McGinley M.P., Goldschmidt C.H., Rae-Grant A.D. Diagnosis and treatment of multiple sclerosis. JAMA. 2021;325:765&#x2013;779. doi: 10.1001/jama.2020.26858.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.26858</ArticleId><ArticleId IdType="pubmed">33620411</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldschmidt C.H., McGinley M.P. Advances in the treatment of multiple sclerosis. Neurol. Clin. 2021;39:21&#x2013;33. doi: 10.1016/j.ncl.2020.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2020.09.002</ArticleId><ArticleId IdType="pmc">PMC7687744</ArticleId><ArticleId IdType="pubmed">33223085</ArticleId></ArticleIdList></Reference><Reference><Citation>Tepav&#x10d;evi&#x107; V., Lubetzki C. Oligodendrocyte progenitor cell recruitment and remyelination in multiple sclerosis: The more, the merrier? Brain. 2022;145:4178&#x2013;4192. doi: 10.1093/brain/awac307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awac307</ArticleId><ArticleId IdType="pubmed">36093726</ArticleId></ArticleIdList></Reference><Reference><Citation>Eleuteri C., Olla S., Veroni C., Umeton R., Mechelli R., Romano S., Buscarinu M., Ferrari F., Cal&#xf2; G., Ristori G., et al. A Staged Screening of Registered Drugs Highlights Remyelinating Drug Candidates for Clinical Trials. Sci. Rep. 2017;7:45780. doi: 10.1038/srep45780.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep45780</ArticleId><ArticleId IdType="pmc">PMC5384285</ArticleId><ArticleId IdType="pubmed">28387380</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo W., Xu H., Xu L., Jiang W., Chen C., Chang Y., Liu C., Tian Z., Qiu X., Xie C., et al. Remyelination in neuromyelitis optica spectrum disorder is promoted by edaravone through mTORC1 signaling activation. Glia. 2023;71:284&#x2013;304. doi: 10.1002/glia.24271.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.24271</ArticleId><ArticleId IdType="pubmed">36089914</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakhtiari M., Ghasemi N., Salehi H., Amirpour N., Kazemi M., Mardani M. Evaluation of Edaravone effects on the differentiation of human adipose derived stem cells into oligodendrocyte cells in multiple sclerosis disease in rats. Life Sci. 2021;282:119812. doi: 10.1016/j.lfs.2021.119812.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2021.119812</ArticleId><ArticleId IdType="pubmed">34265362</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho H., Shukla S. Role of Edaravone as a Treatment Option for Patients with Amyotrophic Lateral Sclerosis. Pharmaceuticals. 2021;14:29. doi: 10.3390/ph14010029.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph14010029</ArticleId><ArticleId IdType="pmc">PMC7823603</ArticleId><ArticleId IdType="pubmed">33396271</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziegler S., Pries V., Hedberg C., Waldmann H. Target Identification for Small Bioactive Molecules: Finding the Needle in the Haystack. Angew. Chem. Int. Ed. 2013;52:2744&#x2013;2792. doi: 10.1002/anie.201208749.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anie.201208749</ArticleId><ArticleId IdType="pubmed">23418026</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar B., Verma R.K. Esterification at Room Temperature: A Mixing Affair Only. Synth. Commun. 1984;14:1359&#x2013;1363. doi: 10.1080/00397918408057676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00397918408057676</ArticleId></ArticleIdList></Reference><Reference><Citation>Queiroz A.N., Martins C.C., Santos K.L.B., Carvalho E.S., Owiti A.O., Oliveira K.R.M., Herculano A.M., da Silva A.B.F., Borges R.S. Experimental and Theoretical Study on Structure-Tautomerism among Edaravone, Isoxazolone, and Their Heterocycles Derivatives as Antioxidants. Saudi Pharm. J. 2020;28:819&#x2013;827. doi: 10.1016/j.jsps.2020.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsps.2020.06.001</ArticleId><ArticleId IdType="pmc">PMC7335820</ArticleId><ArticleId IdType="pubmed">32647483</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y., Smith R., Vivoli M., Ema M., Goos N., Gehrke S., Harmer N.J., Wagner G.K. Covalent inhibitors of LgtC: A blueprint for the discovery of non-substrate-like inhibitors for bacterial glycosyltransferases. Bioorg. Med. Chem. 2017;25:3182&#x2013;3194. doi: 10.1016/j.bmc.2017.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmc.2017.04.006</ArticleId><ArticleId IdType="pubmed">28462843</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang J., Sigua L.H., Chan A., Kalra P., Pomerantz W.C.K., Sch&#xf6;nbrunn E., Qi J., Georg G.I. Dihydropyridine lactam analogs targeting BET bromodomains. ChemMedChem. 2022;17:e202100407. doi: 10.1002/cmdc.202100407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cmdc.202100407</ArticleId><ArticleId IdType="pmc">PMC8762755</ArticleId><ArticleId IdType="pubmed">34932262</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghasemi M., Turnbull T., Sebastian S., Kempson I. The MTT Assay: Utility, Limitations, Pitfalls, and Interpretation in Bulk and Single-Cell Analysis. Int. J. Mol. Sci. 2021;22:12827. doi: 10.3390/ijms222312827.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms222312827</ArticleId><ArticleId IdType="pmc">PMC8657538</ArticleId><ArticleId IdType="pubmed">34884632</ArticleId></ArticleIdList></Reference><Reference><Citation>Minnelli C., Laudadio E., Galeazzi R., Rusciano D., Armeni T., Stipa P., Cantarini M., Mobbili G. Synthesis, Characterization and Antioxidant Properties of a New Lipophilic Derivative of Edaravone. Antioxidants. 2019;8:258. doi: 10.3390/antiox8080258.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox8080258</ArticleId><ArticleId IdType="pmc">PMC6720979</ArticleId><ArticleId IdType="pubmed">31370225</ArticleId></ArticleIdList></Reference><Reference><Citation>QikProp  . Small-Molecule Drug Discovery Suite 2021-1. Schrodinger, LLC; New York, NY, USA: 2021.  [(accessed on 8 September 2020)].  Available online:  https://www.schrodinger.com/products/qikprop.</Citation></Reference><Reference><Citation>Bochevarov A.D., Harder E., Hughes T.F., Greenwood J.R., Braden D.A., Philipp D.M., Rinaldo D., Halls M.D., Zhang J., Friesner R.A. Jaguar: A high-performance quantum chemistry software program with strengths in life and materials sciences. Int. J. Quantum Chem. 2013;113:2110&#x2013;2142. doi: 10.1002/qua.24481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/qua.24481</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam N. Investigation of comparative shielding of Morin against oxidative damage by radicals: A DFT study. Cogent Chem. 2015;1:1078272. doi: 10.1080/23312009.2015.1078272.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23312009.2015.1078272</ArticleId></ArticleIdList></Reference><Reference><Citation>Kremer D., Akkermann R., K&#xfc;ry P., Dutta R. Current advancements in promoting remyelination in multiple sclerosis. Mult. Scler. J. 2019;25:7&#x2013;14. doi: 10.1177/1352458518800827.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1352458518800827</ArticleId><ArticleId IdType="pmc">PMC6389436</ArticleId><ArticleId IdType="pubmed">30270725</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe K., Morinaka Y., Iseki K., Watanabe T., Yuki S., Nishi H. Structure&#x2013;activity relationship of 3-methyl-1-phenyl-2-pyrazolin-5-one (edaravone) Redox Rep. 2003;8:151&#x2013;155. doi: 10.1179/135100003225001520.</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/135100003225001520</ArticleId><ArticleId IdType="pubmed">12935312</ArticleId></ArticleIdList></Reference><Reference><Citation>Nevitt T., Ohrvik H., Thiele D.J. Charting the travels of copper in eukaryotes from yeast to mammals. Biochim. Biophys. Acta. 2012;182:1580&#x2013;1593. doi: 10.1016/j.bbamcr.2012.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2012.02.011</ArticleId><ArticleId IdType="pmc">PMC3392525</ArticleId><ArticleId IdType="pubmed">22387373</ArticleId></ArticleIdList></Reference><Reference><Citation>Singleton V., Orthofer R., Lamuela-Raventos R.M. Analysis of total phenols and other oxidation substrates and antioxidants by means of Folin-Ciocalteu reagent. Methods Enzymol. 1999;299:152&#x2013;178. doi: 10.1016/S0076-6879(99)99017-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0076-6879(99)99017-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Becke A.D. Density-functional thermochemistry. III. The role of exact exchange. J. Chem. Phys. 1993;98:5648&#x2013;5652. doi: 10.1063/1.464913.</Citation><ArticleIdList><ArticleId IdType="doi">10.1063/1.464913</ArticleId></ArticleIdList></Reference><Reference><Citation>Marenich A.V., Cramer C.J., Truhlar D.G. Universal solvation model based on solute electron density and on a continuum model of the solvent defined by the bulk dielectric constant and atomic surface tensions. J. Phys. Chem. B. 2009;113:6378&#x2013;6396. doi: 10.1021/jp810292n.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jp810292n</ArticleId><ArticleId IdType="pubmed">19366259</ArticleId></ArticleIdList></Reference><Reference><Citation>Holzer W., Plagens B., Lorenz K. Alkylation of Pyrazolones via the Mitsunobu Reaction. Heterocycles. 1997;45:309&#x2013;314. doi: 10.3987/COM-96-7657.</Citation><ArticleIdList><ArticleId IdType="doi">10.3987/COM-96-7657</ArticleId></ArticleIdList></Reference><Reference><Citation>Haessner R., Hennig L., Gaca J. 13C NMR Data for Chlorine- or Nitro-Substituted Azomethine Dyes. Magn. Reson. Chem. 1990;28:817&#x2013;819. doi: 10.1002/mrc.1260280915.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrc.1260280915</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan W., Li W., Ma X., Tao X., Li X., Yao Y., Xie X., Zhang Z. Ru-Catalyzed Asymmetric Hydrogenation of &#x3b3;-Heteroatom Substituted &#x3b2;-Keto Esters. J. Org. Chem. 2011;76:9444&#x2013;9451. doi: 10.1021/jo201822k.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jo201822k</ArticleId><ArticleId IdType="pubmed">21981465</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotha S., Shirbhate M.E. Diversity-Oriented Approach to Macrocyclic Cyclophane Derivatives via RingClosing Metathesis. Synlett. 2012;23:2183&#x2013;2188. doi: 10.1055/s-0032-1317020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0032-1317020</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>